全文获取类型
收费全文 | 899篇 |
免费 | 64篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 42篇 |
妇产科学 | 24篇 |
基础医学 | 95篇 |
口腔科学 | 12篇 |
临床医学 | 76篇 |
内科学 | 232篇 |
皮肤病学 | 15篇 |
神经病学 | 51篇 |
特种医学 | 157篇 |
外国民族医学 | 1篇 |
外科学 | 76篇 |
综合类 | 33篇 |
一般理论 | 1篇 |
预防医学 | 47篇 |
眼科学 | 5篇 |
药学 | 62篇 |
中国医学 | 6篇 |
肿瘤学 | 36篇 |
出版年
2023年 | 6篇 |
2022年 | 6篇 |
2021年 | 9篇 |
2020年 | 3篇 |
2019年 | 13篇 |
2018年 | 7篇 |
2016年 | 27篇 |
2015年 | 47篇 |
2014年 | 18篇 |
2013年 | 26篇 |
2012年 | 23篇 |
2011年 | 31篇 |
2010年 | 32篇 |
2009年 | 33篇 |
2008年 | 33篇 |
2007年 | 21篇 |
2006年 | 25篇 |
2005年 | 30篇 |
2004年 | 28篇 |
2003年 | 28篇 |
2002年 | 16篇 |
2001年 | 24篇 |
2000年 | 21篇 |
1999年 | 20篇 |
1998年 | 30篇 |
1997年 | 48篇 |
1996年 | 37篇 |
1995年 | 33篇 |
1994年 | 27篇 |
1993年 | 24篇 |
1992年 | 11篇 |
1991年 | 15篇 |
1990年 | 20篇 |
1989年 | 29篇 |
1988年 | 24篇 |
1987年 | 14篇 |
1986年 | 20篇 |
1985年 | 12篇 |
1984年 | 12篇 |
1983年 | 10篇 |
1982年 | 13篇 |
1981年 | 10篇 |
1980年 | 10篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1977年 | 6篇 |
1976年 | 6篇 |
1974年 | 3篇 |
1962年 | 3篇 |
1960年 | 2篇 |
排序方式: 共有973条查询结果,搜索用时 0 毫秒
1.
The flow cytometric crossmatch and early renal transplant loss 总被引:3,自引:0,他引:3
R J Mahoney K A Ault S R Given R J Adams A C Breggia P A Paris G E Palomaki S A Hitchcox B W White J Himmelfarb 《Transplantation》1990,49(3):527-535
Data from this retrospective study indicate that a positive two-color T and/or B cell flow cytometric crossmatch (FCXM) is predictive of early renal allograft loss (less than 2 months) in cadaveric kidney donor recipients who had a negative crossmatch by the antihuman globulin complement-dependent cytotoxicity technique. Among 90 cadaveric kidney donor recipients (67 primary, 23 regrafts), 14 (8 primary, 6 regrafts) lost their renal allografts within 2 months, and 10 of the 14 were FCXM positive and HLA sensitized. The remaining 76 allografts survived beyond 2 months, 12 of which were FCXM-positive. Thus, the FCXM sensitivity rate for detecting early graft loss was 71%, and the specificity rate was 84%. Cadaveric graft-loss rates at 2 months were 33% for primary and 60% for FCXM-positive regrafts in contrast to 7% for primary and 0% for FCXM-negative regrafts. The difference in early graft loss between FCXM-positive and FCXM-negative recipients was statistically significant (P less than 0.0001). Subset analyses of FCXM-positive graft recipients indicate: (1) previous early graft loss contraindicates transplantation of an FXCM-positive regraft (P = 0.03); and (2) panel reactive antibody (PRA) less than or equal to 10% at crossmatch is not associated with early graft loss (P = 0.04). There was no significant difference in 1-year graft survival between primary and regrafts in either FCXM-negative recipients (85% vs. 77%, respectively) or FCXM-positive recipients (67% vs. 40%). All 12 of the FCXM-positive primary and regrafts that survived 2 months continued to function at 2 years. Stepwise logistic regression analysis of 5 independent predictor variables (FCXM status, gender, primary vs. regraft status, PRA level, and HLA mismatched antigens) indicated that the FCXM test was the best predictor of early graft loss. When FCXM results of the 90 cadaveric graft recipients were ranked in three groups, an FCXM channel shift of 29 or greater (third tertile) on a 1024 channel log scale was associated with a 7.0-fold (95% confidence interval 1.9-25.5) increased risk of early graft failure when compared to the first two tertiles. These data indicate that the FCXM offers an additional approach for identifying sensitized patients at risk of early renal allograft loss. 相似文献
2.
3.
4.
Hausegger KA; Cragg AH; Lammer J; Lafer M; Fluckiger F; Klein GE; Sternthal MH; Pilger E 《Radiology》1994,190(1):199
5.
The kidneys of six progressive multifocal leukoencephalopathy (PML) patients were examined by PCR amplification for the presence of JC virus. Amplification of three different areas of the viral genome from multiple samples of each kidney revealed three that were positive for the virus. The use of a PCR-based typing assay on all tissue samples, and cloned sequences from the viral coding region from each positive kidney showed that the same viral genome was present in the kidney as in the brain of the patient. Regulatory region clones all had the archetypal promoter/enhancer structure. However, when PCR fragments from the regulatory region were digested with a restriction enzyme which cuts in region D, the region most often deleted in PML-type promoters, a low level of undigested DNA remained. This DNA refractory to digestion had a rearranged sequence identical to that of the unique rearranged promoter in the brain of each patient. © 1994 Wiley-Liss, Inc. 相似文献
6.
7.
8.
9.
10.